{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:10:09Z","timestamp":1778602209055,"version":"3.51.4"},"reference-count":14,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"unspecified","delay-in-days":76,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Neurol Open"],"accepted":{"date-parts":[[2026,3,1]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Dopamine dysregulation syndrome (DDS) is an uncommon but debilitating complication of Parkinson\u2019s disease (PD), characterised by a compulsive overuse of dopaminergic therapy. Most reported cases are male and involve daily oral levodopa (L-DOPA) intake between 2000 and 4000\u2009mg.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We describe a female with young-onset PD who progressively escalated oral L-DOPA intake to a peak of 10\u2009000\u2009mg\/day prior to subthalamic nucleus deep brain stimulation (DBS). A structured psychiatric assessment was performed after DBS. Whole-exome sequencing was conducted to evaluate possible genetic susceptibility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The patient developed compulsive medication use, impulse control disorders and gingival black pigmentation with near-total tooth loss. Classical hedonistic DDS features were absent. Following DBS, the L-DOPA dose stabilised at 1800\u2009mg\/day, but psychosis emerged, requiring hospitalisation. Genetic testing did not identify a pathogenic cause for early-onset PD; a rare missense variant of uncertain significance was detected without established clinical relevance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This case represents the highest sustained oral L-DOPA dose reported in PD. Despite lacking several core DDS features, the pattern of compulsive use suggests dopaminergic dysregulation. This case highlights limitations in current DDS criteria and suggests that contextual features, such as motor disability, psychological reinforcement and individual vulnerability, should be integrated into future refinements.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjno-2025-001498","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:20:28Z","timestamp":1773872428000},"page":"e001498","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["At the extreme limits of L-DOPA therapy: probable dopamine dysregulation and psychiatric complications in Parkinson\u2019s disease"],"prefix":"10.1136","volume":"8","author":[{"given":"Niko","family":"Oikarinen","sequence":"first","affiliation":[{"name":"Clinical Neurosciences, University of Turku, Turku, Finland"},{"name":"Neurocenter, Turku University Hospital, Turku, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Ottela","sequence":"additional","affiliation":[{"name":"Clinical Neurosciences, University of Turku, Turku, Finland"},{"name":"Neurocenter, Turku University Hospital, Turku, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaana","family":"R\u00f6nk\u00e4","sequence":"additional","affiliation":[{"name":"Clinical Neurosciences, University of Turku, Turku, Finland"},{"name":"Neurocenter, Turku University Hospital, Turku, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Haanp\u00e4\u00e4","sequence":"additional","affiliation":[{"name":"Department of Genomics, Turku University Hospital, Turku, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solja","family":"Niemel\u00e4","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Turku and Turku University Hospital, Turku, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew John","family":"Lees","sequence":"additional","affiliation":[{"name":"Reta Lila Weston Institute, Institute of Neurology, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3446-7093","authenticated-orcid":false,"given":"Valtteri","family":"Kaasinen","sequence":"additional","affiliation":[{"name":"Clinical Neurosciences, University of Turku, Turku, Finland"},{"name":"Neurocenter, Turku University Hospital, Turku, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"2026051208153504000_8.1.e001498.1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.68.4.423"},{"key":"2026051208153504000_8.1.e001498.2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200923020-00005"},{"key":"2026051208153504000_8.1.e001498.3","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20822"},{"key":"2026051208153504000_8.1.e001498.4","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-315985"},{"key":"2026051208153504000_8.1.e001498.5","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddv281"},{"key":"2026051208153504000_8.1.e001498.6","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3389\/fgene.2018.00725","article-title":"Exome Sequencing Identifies TENM4 as a Novel Candidate Gene for Schizophrenia in the SCZD2 Locus at 11q14-21","volume":"9","author":"Xue","year":"2018","journal-title":"Front Genet"},{"key":"2026051208153504000_8.1.e001498.7","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.582323","article-title":"A Han Chinese Family With Early-Onset Parkinson\u2019s Disease Carrying Novel Frameshift Mutation and Compound Heterozygous Mutation of PRKN Appearing Incompatible With MDS Clinical Diagnostic Criteria","volume":"11","author":"Gao","year":"2020","journal-title":"Front Neurol"},{"key":"2026051208153504000_8.1.e001498.8","article-title":"Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson\u2019s Disease Receiving \u22652000\u2009mg Daily Dose of Levodopa","volume":"2020","author":"Zadikoff","year":"2020","journal-title":"Parkinsons Dis"},{"key":"2026051208153504000_8.1.e001498.9","doi-asserted-by":"publisher","DOI":"10.1037\/amp0000059"},{"key":"2026051208153504000_8.1.e001498.10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3233\/JPD-2011-11021","article-title":"Dry mouth: an overlooked autonomic symptom of Parkinson\u2019s disease","volume":"1","author":"Cersosimo","year":"2011","journal-title":"J Parkinsons Dis"},{"key":"2026051208153504000_8.1.e001498.11","doi-asserted-by":"publisher","DOI":"10.1111\/odi.12622"},{"key":"2026051208153504000_8.1.e001498.12","doi-asserted-by":"crossref","DOI":"10.1016\/j.archoralbio.2023.105712","article-title":"Parkinson\u2019s disease and oral health: A systematic review","volume":"151","author":"Verhoeff","year":"2023","journal-title":"Arch Oral Biol"},{"key":"2026051208153504000_8.1.e001498.13","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25696"},{"key":"2026051208153504000_8.1.e001498.14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/acn3.51248","article-title":"Rare variant analysis of essential tremor-associated genes in early-onset Parkinson\u2019s disease","volume":"8","author":"Liang","year":"2021","journal-title":"Ann Clin Transl Neurol"}],"container-title":["BMJ Neurology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjno-2025-001498","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:17:05Z","timestamp":1778599025000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurologyopen.bmj.com\/lookup\/doi\/10.1136\/bmjno-2025-001498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3,18]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/bmjno-2025-001498"],"URL":"https:\/\/doi.org\/10.1136\/bmjno-2025-001498","relation":{},"ISSN":["2632-6140"],"issn-type":[{"value":"2632-6140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}